Ligand Pharmaceuticals Incorporated (LGND)
Healthcare • Biotechnology
StockNasdaqGMUnited StatesUS53220K5048
310.63 USD
-1.78% today Updated 13 Nov 2026 16:28
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Ligand Pharmaceuticals Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:28. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 08:00 · estimate 2.88
Last results
2.67 vs 2.33 estimated
29 Oct 2026 · Beat +14.7%
Beat the estimate
11 of 12
1 missed · 0 in line · 2 beats in a row
Average surprise
+31.1%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 2.88 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 2.33 | 2.67 | +14.7% | Beat |
| 06 Aug 2026 07:00 | 1.95 | 2.37 | +21.5% | Beat |
| 07 May 2026 07:00 | 1.80 | 1.63 | -9.6% | Miss |
| 26 Feb 2026 07:00 | 1.50 | 2.02 | +34.9% | Beat |
| 06 Nov 2025 07:00 | 1.93 | 3.09 | +60.5% | Beat |
| 07 Aug 2025 07:00 | 1.42 | 1.60 | +12.6% | Beat |
| 08 May 2025 07:00 | 1.21 | 1.33 | +9.7% | Beat |
| 27 Feb 2025 07:00 | 1.19 | 1.27 | +6.7% | Beat |
| 07 Nov 2024 07:00 | 1.35 | 1.84 | +36.7% | Beat |
| 06 Aug 2024 16:00 | 1.06 | 1.40 | +32.6% | Beat |
| 08 May 2024 16:00 | 0.83 | 1.20 | +43.9% | Beat |
| 27 Feb 2024 07:00 | 0.66 | 1.38 | +108.9% | Beat |
| 08 Nov 2023 16:00 | 0.62 | 1.02 | +64.5% | Beat |
| 08 Aug 2023 16:00 | 0.66 | 1.42 | +114.6% | Beat |
| 04 May 2023 16:00 | 0.89 | 2.28 | +155.0% | Beat |
| 22 Feb 2023 16:00 | 1.12 | 1.36 | +21.6% | Beat |
| 07 Nov 2022 16:00 | 0.43 | 1.31 | +203.4% | Beat |
| 08 Aug 2022 16:00 | 0.43 | 1.03 | +139.8% | Beat |
| 04 May 2022 16:00 | 0.66 | 0.76 | +15.7% | Beat |
| 17 Feb 2022 16:00 | 1.37 | 1.80 | +31.4% | Beat |
| 09 Nov 2021 16:00 | 1.04 | 1.58 | +52.4% | Beat |
| 29 Jul 2021 16:00 | 1.36 | 1.63 | +19.7% | Beat |
| 03 May 2021 16:00 | 1.13 | 1.41 | +25.3% | Beat |
| 03 Feb 2021 07:00 | 1.09 | 1.62 | +48.6% | Beat |
| 30 Oct 2020 08:00 | 0.98 | 1.04 | +5.9% | Beat |
| 03 Aug 2020 07:00 | 0.76 | 1.00 | +31.3% | Beat |
| 06 May 2020 17:00 | 0.66 | 0.89 | +34.9% | Beat |
| 06 Feb 2020 16:00 | 0.65 | 0.71 | +10.1% | Beat |
| 05 Nov 2019 16:00 | 0.62 | 0.49 | -20.7% | Miss |
| 30 Jul 2019 08:00 | 0.55 | 0.68 | +24.2% | Beat |
| 02 May 2019 16:00 | 15.45 | 1.16 | -92.5% | Miss |
| 07 Feb 2019 16:00 | 1.22 | 1.70 | +39.3% | Beat |
| 08 Nov 2018 08:00 | 1.03 | 1.32 | +28.4% | Beat |
| 06 Aug 2018 16:00 | 2.38 | 2.59 | +8.7% | Beat |
| 08 May 2018 16:00 | 1.26 | 1.55 | +22.6% | Beat |
| 21 Feb 2018 16:00 | 1.19 | 1.31 | +9.8% | Beat |
| 09 Nov 2017 16:00 | 0.61 | 0.69 | +12.4% | Beat |
| 07 Aug 2017 16:00 | 0.46 | 0.67 | +45.7% | Beat |
| 09 May 2017 16:00 | 0.72 | 0.57 | -20.8% | Miss |
| 23 Feb 2017 16:00 | 1.32 | 1.25 | -5.3% | Miss |
| 03 Nov 2016 16:00 | 0.59 | 0.62 | +4.7% | Beat |
| 04 Aug 2016 08:00 | 0.53 | 0.50 | -5.7% | Miss |
| 04 May 2016 06:00 | 0.65 | 0.97 | +48.3% | Beat |
| 10 Feb 2016 16:00 | 0.64 | 0.66 | +3.1% | Beat |
| 09 Nov 2015 16:00 | 0.41 | 0.56 | +36.6% | Beat |
| 04 Aug 2015 16:00 | 1.03 | 1.81 | +74.9% | Beat |
| 11 May 2015 08:00 | 0.27 | 0.33 | +22.2% | Beat |
| 09 Feb 2015 08:00 | 0.61 | 0.60 | -1.1% | Miss |
| 27 Oct 2014 08:00 | 0.36 | 0.36 | 0.0% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 268.1M | +60.4% | 124.5M | 46.4% | 6.13 | +2,886.4% | 38M |
| 2024 | 167.1M | +27.3% | -4M | -2.4% | -0.22 | -107.5% | 77.4M |
| 2023 | 131.3M | -33.1% | 52.2M | 39.7% | 2.94 | +248.5% | -4.3M |
| 2022 | 196.2M | — | -33.4M | -17.0% | -1.98 | — | 119.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 323.28 | 325.96 | 297.63 | 310.63 | -3.76% | 1,730,290 | |
| Oct 2026 | 309.82 | 324.90 | 281.74 | 322.75 | +3.32% | 5,241,800 | |
| Sep 2026 | 286.28 | 317.23 | 270.77 | 312.37 | +9.95% | 5,370,900 | |
| Aug 2026 | 287.00 | 317.49 | 275.60 | 284.10 | -1.20% | 4,775,200 | |
| Jul 2026 | 315.20 | 326.63 | 286.22 | 287.54 | -9.03% | 7,438,800 | |
| Jun 2026 | 228.68 | 320.99 | 222.76 | 316.09 | +36.27% | 10,476,700 | |
| May 2026 | 229.87 | 238.76 | 200.01 | 231.96 | +1.09% | 4,323,400 | |
| Apr 2026 | 203.50 | 247.38 | 194.67 | 229.45 | +14.93% | 4,724,300 | |
| Mar 2026 | 197.20 | 227.92 | 188.67 | 199.65 | +0.68% | 5,361,200 | |
| Feb 2026 | 192.18 | 202.79 | 178.72 | 198.31 | +3.23% | 3,521,000 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Barclays Maintains Overweight on Ligand Pharmaceuticals, Raises Price Target to $350 (opens in a new tab) Benzinga · 11 Nov 2026 11:25
- Citigroup Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $402 (opens in a new tab) Benzinga · 05 Nov 2026 18:23
- Ligand Pharmaceuticals: Filspari And XOMA Strengthen The Case For A Buy (opens in a new tab) SeekingAlpha · 04 Nov 2026 16:21
- Ligand Pharmaceuticals Sees Strong Royalty Growth Ahead of Investor Day, Oppenheimer Says (opens in a new tab) MT Newswires · 30 Oct 2026 17:12
- Ligand Pharmaceuticals (LGND) Stock Price Ignores Q3 Earnings Losses And Royalty Strength (opens in a new tab) Simply Wall St. · 30 Oct 2026 17:09
- Ligand (LGND) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 30 Oct 2026 14:46
- Ligand Pharmaceuticals Incorporated Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
- What Ligand Pharmaceuticals (LGND) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 29 Oct 2026 19:14
- Ligand: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 29 Oct 2026 11:20
- Is Ligand Pharmaceuticals (LGND) Below Fair Value As It Funds AvenCell? (opens in a new tab) Simply Wall St. · 29 Sep 2026 17:04
- Ligand Pharmaceuticals (LGND) Stock May Be 27% Undervalued After A New Royalty Deal (opens in a new tab) Simply Wall St. · 29 Sep 2026 11:05
- Is Ligand Pharmaceuticals (LGND) Using AvenCell CAR-T Royalties To Redefine Its Cash-Flow Playbook? (opens in a new tab) Simply Wall St. · 29 Sep 2026 05:25
- Ligand (LGND)-AvenCell Deal: Most of the Funding Is Tied to Milestones (opens in a new tab) Insider Monkey · 27 Sep 2026 14:08
- Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book (opens in a new tab) Insider Monkey · 04 Sep 2026 11:44
- Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital (opens in a new tab) MarketBeat · 26 Aug 2026 18:02
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 316.27 USD
- Market cap
- 6.3B
- Last dividend
- 9.3575 USD · 02 Jul 2010
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 03 Apr 2007 | 9.3575 USD |
Why this score
Similar shares
Follow LGND and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.